Ministry of Science, Innovation and Universities (MICIU), through the Carlos III Health Institute (ISCIII), will allocate 90 million euros to strengthen biomedical and health research in Spain, through three calls.
The three calls will be posted in framework PERTE for Vanguard Health and its Recovery, Transformation and Resilience Plan, and within the framework of the strategic work in health (Architectural and engineering services), the main vehicle for financing health research in Spain, managed by ISCIII.
The three calls will be released as part of the PERTE for Vanguard Health Recovery, Transformation and Resilience Plan.
Secretary General of Research, Eva OrtegaToday he participated in the presentation of these invitations, highlighting the Ministry’s commitment to health research through the Carlos III Health Institute. We have significantly increased the Institute’s budget, starting with €270 million in 2018 to nearly €600 million in 2023“, pointed out.
On the other hand, Ortega stated that “this growth shows us how important this growth is.” Commitment to scientific quality To advance the search for solutions in the field of health, and thus improve the well-being of people, which is the goal that lies at the heart of our policies.
Clinical Research Units
First to think about calls 45 million euros To finance actions to create or consolidate clinical research units in Spain, structures attached to health centres, such as hospitals or primary care centres that may form part of health research institutes, dedicated to supporting Clinical Trial Development With an eye to the needs of the people who participate in it.
Specifically, Spain is the second country in the world in developing clinical trials, and is a center Leadership This call will help strengthen and improve the research capacities of the National Health System (SNS) while providing the infrastructure specifically aimed at this.
This new call includes a New element for paragraphs To the research and innovation capabilities of the social networking system, with criteria for equal access for citizens to available resources. To this end, the program focuses on adequate coverage of the needs of patients participating in clinical trials and their families, with special attention to vulnerable groups, and promoting humanity.
personalized precision medicine
The second call seeks to further strengthen the equitable implementation and regional coherence of precision medicine in Spain. In total, aid worth 25 million euros To finance projects capable of transforming Decision making in clinical practice and public health measuresDevelop safer, more efficient, preventive and predictive medicine, based on the appropriate use of big data and adaptation to individual characteristics that affect health.
The second call seeks to continue promoting the equitable implementation and regional coherence of precision medicine in Spain.
These grants will allow us to continue to deploy specific applications of personalized precision medicine in Spain to advance the field of Early and individual approach These new applications must be supported by the IMPaCT infrastructure, which operates on three main pillars: genomic medicine, predictive medicine, and data science.
Rare diseases and neuromuscular diseases
The third call will be funded, with 20 million eurosprojects in rare diseases and neuromuscular diseases that make it possible to develop and implement clinical care procedures in SNS, which allow to improve prevention, diagnosis, treatment and, ultimately, care for patients and their families. The goal is Coordinated Action Lines FinancingWith regional cohesion and cooperation between autonomous communities.
